Closed System Transfer Devices (CSTDs) play a critical role in protecting the health of pharmacy staff during hazardous drug compounding. Each year, over 8 million
Mark Stanfield has had a diverse career path, starting as a musician and later working in Hollywood producing television commercials. However, after the events of
EQUASHIELD® is excited to announce that we will be hosting, alongside Pharmacy Stars, a webinar on July 11th, 2024 at 12:30pm EST. This webinar will
AI has been heralded as the future of production lines, providing a level of automation and control that is unparalleled- surpassing limited human visual perception
ASHP Pharmacy Futures 2024 | June 9 – 11, 2024 | Portland, OR “The brand-new dynamic summer event brings together pharmacy practitioners, practice leaders, and
We are thrilled to announce that the EQUASHIELD® Syringe Unit has received additional FDA clearance for full volume use. This achievement marks a significant milestone
The ongoing battle against cancer has seen a paradigm shift with the advent of CAR-T cell therapy, a revolutionary approach that utilizes the patient’s own
Introduction Chemotherapy drugs, vital in cancer treatment, are not without risks for healthcare professionals, particularly nurses. Their handling poses occupational hazards due to the drugs’
Q: How does USP <800> refer to closed system transfer devices (CSTDs)? A: CSTDs are referred to as a containment supplemental engineering control that provide
The Mundus Mini HD from EQUASHIELD improves hazardous drug compounding with advanced automation that instills safety, quality, and efficiency. The critical element is the Closed-Back
